HuGE Literature Finder
Records
1
-
28
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 2021 Jun . Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Sasaki Koji, Darbaniyan Faezeh, Jabbour Elias, Bueso-Ramos Carlos, Wei Yue, Chien Kelly, Kadia Tapan, Ravandi Farhad, Borthakur Gautam, Soltysiak Kelly A, Routbort Mark, Patel Keyur, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop, Garcia-Manero Guiller |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
| TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes. Blood cells, molecules & diseases 2019 Feb 74 44-50. Hu Jinjun, Xu Jing, Tian Tingting, Xie Juan, Fan Lifang, Zhu Guiyang, Xia Ting, Chen Xi, Tan Yanhong, Chen Xiuhua, Ren Fanggang, Zhang Yaofang, Wang Hongwei, Xu Zhifa |
| Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes. International journal of hematology 2018 Dec 108 (6): 598-606. Shingai Naoki, Harada Yuka, Iizuka Hiroko, Ogata Yosuke, Doki Noriko, Ohashi Kazuteru, Hagihara Masao, Komatsu Norio, Harada Hirono |
| Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis. Hematology (Amsterdam, Netherlands) 2018 May 1-7. Arbab Jafari Pourya, Ayatollahi Hossein, Sadeghi Ramin, Sheikhi Maryam, Asghari Am |
| Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine. Oncotarget 2018 Apr 9 (27): 19342-19355. Cabezón Marta, Bargay Joan, Xicoy Blanca, García Olga, Borrás Josep, Tormo Mar, Marcé Sílvia, Pedro Carme, Valcárcel David, Jiménez Maria-José, Guàrdia Ramón, Palomo Laura, Brunet Salut, Vall-Llovera Ferran, Garcia Antoni, Feliu Evarist, Zamora Lurdes, |
| Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of cancer research and clinical oncology 2018 Mar . Lin Peipei, Luo Yingwan, Zhu Shuanghong, Maggio Dominic, Yang Haiyang, Hu Chao, Wang Jinghan, Zhang Hua, Ren Yanling, Zhou Xinping, Mei Chen, Ma Liya, Xu Weilai, Ye Li, Zhuang Zhengping, Jin Jie, Tong Hongy |
| Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model. American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Mar 38 (3): 192-197. Wang J Y, Ma J, Lin Y N, Wang J, Shen H, Gui F M, Han C, Li Q H, Song Z, Wang X |
| Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis. PloS one 2017 12 (9): e0185053. Zheng Xue, Zhan Zhi, Naren Duolan, Li Jing, Yan Tianyou, Gong Yupi |
| Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations. Oncotarget 2016 Feb . Aslan Derya, Garde Christian, Nygaard Mette Katrine, Helbo Alexandra Søgaard, Dimopoulos Konstantinos, Hansen Jakob Werner, Severinsen Marianne Tang, Treppendahl Marianne Bach, Sjø Lene Dissing, Grønbæk Kirsten, Kristensen Lasse Somm |
| Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. American journal of hematology 2016 Jan . Hamilton Betty Ky, Visconte Valeria, Jia Xuefei, Tabarroki Ali, Makishima Hideki, Hasrouni Edy, Abounader Donna, Kalaycio Matt, Sekeres Mikkael A, Sobecks Ronald, Duong Liu Hien, Bolwell Brian, Maciejewski Jaroslaw P, Copelan Edward, Tiu Ramon |
| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell reports 2015 Mar 10 (8): 1239-45. McKerrell Thomas, Park Naomi, Moreno Thaidy, Grove Carolyn S, Ponstingl Hannes, Stephens Jonathan, , Crawley Charles, Craig Jenny, Scott Mike A, Hodkinson Clare, Baxter Joanna, Rad Roland, Forsyth Duncan R, Quail Michael A, Zeggini Eleftheria, Ouwehand Willem, Varela Ignacio, Vassiliou George |
| The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. BMC cancer 2015 15 484. Kang Min-Gu, Kim Hye-Ran, Seo Bo-Young, Lee Jun Hyung, Choi Seok-Yong, Kim Soo-Hyun, Shin Jong-Hee, Suh Soon-Pal, Ahn Jae-Sook, Shin Myung-Ge |
| The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia. Human pathology 2014 Dec 45 (12): 2471-9. Federmann Birgit, Abele Manuel, Rosero Cuesta David Santiago, Vogel Wichard, Boiocchi Leonardo, Kanz Lothar, Quintanilla-Martinez Leticia, Orazi Attilio, Bonzheim Irina, Fend Fal |
| Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact. British journal of haematology 2014 Mar 164 (6): 822-33. Bacher Ulrike, Haferlach Torsten, Schnittger Susanne, Zenger Melanie, Meggendorfer Manja, Jeromin Sabine, Roller Andreas, Grossmann Vera, Krauth Maria-Theresa, Alpermann Tamara, Kern Wolfgang, Haferlach Claud |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014 Feb 28 (2): 241-7. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler H P, Klein H-U, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa |
| Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
| Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors. International journal of cancer. Journal international du cancer 2012 Dec . Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH |
| SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival. Blood 2012 Nov 120 (20): 4168-71. Lasho Terra L, Jimma Thitina, Finke Christy M, Patnaik Mrinal, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
| Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (27): 3376-82. Bejar Rafael, Stevenson Kristen E, Caughey Bennett A, Abdel-Wahab Omar, Steensma David P, Galili Naomi, Raza Azra, Kantarjian Hagop, Levine Ross L, Neuberg Donna, Garcia-Manero Guillermo, Ebert Benjamin |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
- Page last reviewed:Jul 25, 2022
- Page last updated:Nov 30, 2022
- Content source: